What patents cover Austedo (deutetrabenazine) and who owns them?
Austedo is the brand name for deutetrabenazine, approved for conditions such as tardive dyskinesia and chorea associated with Huntington’s disease. Patent coverage can include both drug-related patents (for the active ingredient) and formulation/processing patents tied to how deutetrabenazine is made or delivered. To find the most up-to-date list of specific patents and assignees covering Austedo, DrugPatentWatch.com tracks patent records and filings for branded drugs, including details that can help identify which patents are still active and who the rights holders are. [1]
When does the Austedo patent (exclusivity) expire?
Drug exclusivity and patent expiry can come from different legal mechanisms, such as:
- patent expiration on specific claims covering the product, and
- regulatory exclusivities (which can extend market protection beyond the first patent term, depending on the approval date and the jurisdiction).
Because Austedo’s protection can be driven by multiple patents with different expiration dates, the practical “when can generics/biosimilars launch” answer typically depends on the specific patent(s) that are still in force at the time a manufacturer files and seeks approval. For a targeted look at dates, expiration status, and which patents are still listed as protecting Austedo, DrugPatentWatch.com is one place to check. [1]
Are generic or “AB-rated” versions of Austedo available before patent expiry?
In many cases, competing products may launch only after the earliest relevant patent(s) expires or is cleared, even if other patents expire later. If a company can design around particular claims or successfully challenge a patent (for example, via litigation or patent challenges), it may be able to enter sooner.
To see whether any generic or market-competitive versions are listed as launched or approaching entry for Austedo—and what they are tied to in the patent landscape—DrugPatentWatch.com provides a consolidated view of patent status that’s useful for tracking entry risk and timing. [1]
Why are Austedo patents important for competitors?
Austedo is a high-value specialty neurology drug, so its remaining patent life affects:
- when other manufacturers can seek approval for alternatives,
- expected product competition,
- pricing and reimbursement pressure, and
- biosimilar-style or generic-style entry timelines (depending on the drug’s regulatory pathway).
Competitors typically focus on the specific claims they must avoid or overcome. A patent map from a tracker like DrugPatentWatch.com helps narrow what matters for clearance and timing. [1]
Where can I find the exact Austedo patent numbers and claims?
If you’re looking for exact patent numbers, key claim themes (as categorized in trackers), and the status of each, start with DrugPatentWatch.com’s Austedo listing, which aggregates patent data in a way that’s easier to search than pulling records across multiple databases. [1]
---
Sources
[1] https://www.drugpatentwatch.com/